The nucleotide sequences of XH209 have been deposited at DDBJ/EMBL/GenBank under the accession number CP009461. The whole-genome shotgun sequencing results for XH210, XH211, XH212, XH213, XH214, XH215 and XH216 have been deposited at DDBJ/EMBL/GenBank under accession numbers JUGC00000000, JTEA00000000, JTEB00000000, JTGO00000000, JTJA00000000, JUBD00000000 and JUBE00000000.

Introduction {#sec001}
============

*Klebsiella pneumoniae* is a gram-negative bacterium of the Enterobacteriaceae family \[[@pone.0165019.ref001]\] that can cause numerous diseases, including pneumonia, urinary tract infections, septicemia, and pyogenic live abscesses \[[@pone.0165019.ref002]\]. Resistance of *K*. *pneumoniae* to carbapenems is increasing worldwide \[[@pone.0165019.ref003]\], and this rise in multidrug resistance has limited the available treatment options for this bacterium, which currently include only colistin, tigecycline, aminoglycosides, and fosfomycin \[[@pone.0165019.ref004]\]. Moreover, strains resistant to tigecycline have been reported \[[@pone.0165019.ref005]--[@pone.0165019.ref008]\].

Tigecycline belongs to the glycylcycline family of antibiotics, which consists of drugs modified from minocycline, and has bacteriostatic activity against a broad spectrum of gram-positive and gram-negative bacteria \[[@pone.0165019.ref009]\]. Compared with tetracycline, tigecycline exhibits increased affinity for the ribosome due to its interaction with 16S rRNA, and this increased affinity proves helpful for overcoming TetM-mediated resistance \[[@pone.0165019.ref010]\]. Resistance to tigecycline is mainly attributed to overproduction of the AcrAB-TolC efflux pump, which is regulated by RamA in *K*. *pneumoniae* \[[@pone.0165019.ref007]\]. *ramA* transcription is de-repressed by the *ramR* mutation in *K*. *pneumoniae* \[[@pone.0165019.ref005]\], and both *rarA* and *marA* provide alternate pathways for RamA-independent tigecycline resistance \[[@pone.0165019.ref011]\]. Moreover, a mechanism for tigecycline resistance independent of the AcrAB-TolC pump has also been identified; mutations in *rpsJ* encoding ribosomal protein S10 and *kpgABC* encoding a putative transporter are associated with AcrAB-TolC-independent tigecycline resistance \[[@pone.0165019.ref006], [@pone.0165019.ref008]\].

In this study, we combined whole-genome sequencing and RNA-Seq to identify putative mutations related to tigecycline resistance in both clinical and laboratory-evolved strains of *K*. *pneumoniae*. Mutations in the *ramR*, *lon*, *ramA* and *rpsJ* genes were observed in the tigecycline-resistant strains. In addition, the fitness costs associated with the mutants were detected to predict the risk of the bacteria spreading in the environment. A transcriptome analysis demonstrated that the *ramR* locus was highly expressed in all tigecycline-resistant strains. To confirm the role of *ramR* and *lon* in tigecycline resistance in *K*. *pneumoniae*, we performed a complementation experiment and constructed a knockout strain.

Materials and Methods {#sec002}
=====================

Bacterial isolates and antimicrobial susceptibility testing {#sec003}
-----------------------------------------------------------

The bacteria evaluated in this study included the clinical isolates XH209 and XH210 \[[@pone.0165019.ref012]\], the laboratory-evolved mutants XH211-XH216 and two gene-knockout mutants (*ramR* XH872 and *lon* XH889) of *K*. *pneumoniae* ([Table 1](#pone.0165019.t001){ref-type="table"}). Strain XH209 was isolated from the blood of a patient in Hangzhou China who was at the beginning of tigecycline treatment, and a strain isolated after the patient received tigecycline treatment was denoted XH210. The MICs were determined by broth microdilution with cation-adjust Mueller-Hinton (MH) broth or by Etest (bioMérieux, Marcy l\'Etoile, France) on MH agar, and the results were interpreted according to the CLSI or EUCAST breakpoints. The bacteria were cultured in Luria-Bertani (LB) or MH (Oxoid, Basingstoke, UK) medium at 37°C. Hygromycin and apramycin were added to the media to final concentrations of 100 mg/L and 50 mg/L, respectively, as necessary.

10.1371/journal.pone.0165019.t001

###### Strains and plasmids used in this study.

![](pone.0165019.t001){#pone.0165019.t001g}

  Strain/plasmid    Isolate day   Parental strain   genotype                                                                                                                 Other genetic changes         Reference
  ----------------- ------------- ----------------- ------------------------------------------------------------------------------------------------------------------------ ----------------------------- --------------------------
  XH209             0             NA                NA                                                                                                                       NA                            this study
  XH210             1             XH209             *ramR* Q122[\*](#t001fn002){ref-type="table-fn"}                                                                         NA                            this study
  XH211             13            XH209             *ramA* Q72L, *lon* Q317[\*](#t001fn002){ref-type="table-fn"} *ramR* Δ190 bp (322--511)                                   *cspE* N57K                   this study
  XH212             13            XH209             P*ramR* +G, *lon* D445V, *rpsJ* V57L                                                                                     *tetA* I235F, 300 kb dup      this study
  XH213             13            XH209             *ramR* A40T, *lon* R33W, *rpoC* Δ18 bp (634--651)                                                                        *eutL* E95Q                   this study
  XH214             13            XH209             *ramR* L58P, *rpoC* G336A                                                                                                                              this study
  XH215             13            XH209             *ramR* Q135[\*](#t001fn002){ref-type="table-fn"}, *lon* Δ 9 bp (791--799), *rpoC* S263Y                                  *yfiR* C89Y *hypo* K302T      this study
  XH216             13            XH209             *ramR* S29[\*](#t001fn002){ref-type="table-fn"}, lon N417K                                                               Mobile element protein G12E   this study
  XH490             1             XH209             *ramR* Q122[\*](#t001fn002){ref-type="table-fn"}                                                                         ND                            this study
  XH491             1             XH209             *ramR* T42Ins (8 bp)                                                                                                     ND                            this study
  XH492             1             XH209             *ramR* S137[\*](#t001fn002){ref-type="table-fn"}                                                                         ND                            this study
  XH493             1             XH209             *ramR* A49Ins (8 bp)                                                                                                     ND                            this study
  XH494             1             XH209             *ramR* M1V                                                                                                               ND                            this study
  XH495             1             XH209             *ramR* W185[\*](#t001fn002){ref-type="table-fn"}                                                                         ND                            this study
  XH496             1             XH209             *ramR* F45Del (8 bp)                                                                                                     ND                            this study
  XH497             1             XH209             *ramR* A2FS                                                                                                              ND                            this study
  XH498             1             XH209             *ramR* F45Ins (8 bp)                                                                                                     ND                            this study
  XH499             1             XH209             *ramR* R107H                                                                                                             ND                            this study
  XH500             1             XH209             *ramR* W89L                                                                                                              ND                            this study
  XH501             1             XH209             *ramR* A37V                                                                                                              ND                            this study
  XH502             1             XH209             *ramR* W89[\*](#t001fn002){ref-type="table-fn"}                                                                          ND                            this study
  XH503             1             XH209             *ramR* T119P                                                                                                             ND                            this study
  XH504             1             XH209             *ramR* K5FS                                                                                                              ND                            this study
  XH505             1             XH209             *ramR* A105G                                                                                                             ND                            this study
  XH466                           XH210             XH210 /pCR2.1-T vector                                                                                                                                 this study
  XH468                           XH210             XH210 /pCR2.1-ramR                                                                                                                                     this study
  XH539                           XH211             XH211 /pCR2.1-T vector                                                                                                                                 this study
  XH540                           XH211             XH211 /pCR2.1-lon                                                                                                                                      this study
  XH583                           XH211             XH211 /pCR2.1-ramR                                                                                                                                     this study
  XH585                           XH211             XH211 /pCR2.1-lon-ramR                                                                                                                                 this study
  XH541                           XH212             XH212 /pCR2.1-T vector                                                                                                                                 this study
  XH593                           XH212             XH212 /pCR2.1-ramR                                                                                                                                     this study
  XH542                           XH212             XH212 /pCR2.1-lon                                                                                                                                      this study
  XH587                           XH212             XH212 /pCR2.1-lon-ramR                                                                                                                                 this study
  XH396                           XH213             XH213 /pCR2.1-T vector                                                                                                                                 this study
  XH398                           XH213             XH213 /pCR2.1-ramR                                                                                                                                     this study
  XH579                           XH213             XH213 /pCR2.1-lon                                                                                                                                      this study
  XH589                           XH213             XH213 /pCR2.1-lon-ramR                                                                                                                                 this study
  XH448                           XH214             XH214 /pCR2.1-T vector                                                                                                                                 this study
  XH452                           XH215             XH215 /pCR2.1-T vector                                                                                                                                 this study
  XH450                           XH214             XH214 /pCR2.1-ramR                                                                                                                                     this study
  XH581                           XH215             XH215 /pCR2.1-lon                                                                                                                                      this study
  XH591                           XH215             XH215 /pCR2.1-lon-ramR                                                                                                                                 this study
  XH456                           XH216             XH216 /pCR2.1-T vector                                                                                                                                 this study
  XH454                           XH215             XH215 /pCR2.1-ramR                                                                                                                                     this study
  XH544                           XH216             XH216 /pCR2.1-lon                                                                                                                                      this study
  XH568                           XH216             XH216 /pCR2.1-lon-ramR                                                                                                                                 this study
  XH872                           XH209             Δ*ramR*::apr                                                                                                                                           this study
  XH889                           XH209             Δ*lon*::apr                                                                                                                                            this study
  XH478                           XH209             XH209 /pACBSR-Hyg                                                                                                                                      this study
  plasmid                                                                                                                                                                                                  
  pCR2.1-T vector                                                                                                                                                                                          Thermo Fisher Scientific
  pCR2.1-ramR                                       pCR2.1-T vector carrying wild-type *ramR*                                                                                                              this study
  pCR2.1-lon                                        pCR2.1-T vector carrying wild-type *lon*                                                                                                               this study
  pCR2.1-lon-ramR                                   pCR2.1-T vector carrying wild-type *ramR* and *lon*                                                                                                    this study
  pIJ773                                            Template for amplification of the apramycin resistance gene                                                                                            Pep Charusanti
  pACBSR-Hyg                                        A p15A replicon plasmid containing an arabinose-inducible λ-Red recombinase and hygromycin resistance selection marker                                 Pep Charusanti

Note:

\*: stop codon;

Δ: Deletion; Ins: Insertion; Del: Deletion; FS: frame shift;

Laboratory evolution of tigecycline-resistant mutants {#sec004}
-----------------------------------------------------

Six independent single colonies of *K*. *pneumoniae* XH209 were grown overnight at 37°C, and the cultures were diluted in LB broth with a serially increasing concentration of tigecycline. The concentration of tigecycline was started at a value equal to 1/2 MIC and doubled every 24 h. The overnight cultures were stored at -80°C for further experiments and analysis \[[@pone.0165019.ref013]\].

The overnight cultures of *K*. *pneumoniae* XH209 were plated on LB plates containing 4 mg/L tigecycline. Mutants were randomly selected from the plates after incubation at 37°C for 24 h and then streaked onto LB plates. The colonies were stored in LB medium with 15% glycerol. The *ramR* gene of the mutants was amplified by PCR and Sanger sequencing \[[@pone.0165019.ref014]\].

Homology modeling {#sec005}
-----------------

RamR structure homology modeling was performed with the SWISS-MODEL workspace using the structure of RamR from *Salmonella Typhimurium* (PDB ID: 3VVX) as a template \[[@pone.0165019.ref015]\]. The 3D structure of the RamR protein was visualized using the PyMOL molecular graphics system, and the positions of the mutations were labeled with the corresponding amino acids.

Whole-genome DNA sequencing and analysis {#sec006}
----------------------------------------

Bacteria from a single colony were cultured overnight at 37°C in MH broth. Genomic DNA was extracted using a QIAamp DNA Mini Kit (Qiagen, Valencia, CA, USA) following the protocol recommended by the manufacturer. Agarose gel electrophoresis and a NanoDrop spectrophotometer were used to determine the quality and quantity of the extracted genomic DNA, respectively. The 300-bp library used for Illumina paired-end sequencing was constructed using 5 μg of genomic DNA from the two clinical strains and six laboratory-evolved mutants. In addition, an 8-kb mate-pair library was prepared for XH209 to complete its genome \[[@pone.0165019.ref016]\]. The raw Illumina data were *de novo* assembled using IDBA-Hybrid \[[@pone.0165019.ref017]\]. The pre-assembled contigs were arranged into scaffolds using SSPACE \[[@pone.0165019.ref018]\], and gaps within the scaffolds were closed with GapFiller \[[@pone.0165019.ref019]\]. Mapping and SNP detection were performed using the CLC Genomics Workbench (CLC bio, Aarhus, Denmark). The regions containing the detected SNPs were amplified by PCR using the primers listed in [S1 Table](#pone.0165019.s001){ref-type="supplementary-material"}. The PCR products were sent to Biosune (Hangzhou, China) for Sanger sequencing.

Growth rate measurement {#sec007}
-----------------------

Four independent cultures of each strain were grown overnight and diluted to 1:1000 in LB, and four replicates of each culture were aliquoted into a flat-bottom 96-well plate. The plate was incubated at 37°C with agitation, and the OD~600~ of each culture was determined every 5 min for 16 h using a BioTEK Synergy plate reader (BioTEK, Winooski, VT, USA). The growth rate was estimated based on the OD~600~ curves using R script \[[@pone.0165019.ref020]\].

RNA-Seq and transcript analysis {#sec008}
-------------------------------

The wild-type and mutant strains were grown overnight in 2 mL of LB broth at 37°C. The overnight cultures were diluted 1:100 in 50 mL of LB broth and incubated at 37°C with shaking for 2 h. The bacteria were pelleted at 4°C, and after grinding in liquid nitrogen, total RNA was extracted using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). Then, 10 U of RNase-free DNase I (Promega, Mannheim, Germany) was added to the samples, and the RNA was purified through phenol-chloroform extraction. The RNA quality and quantity were determined by 1.0% formaldehyde denaturing agarose gel electrophoresis and a NanoDrop ND-1000 spectrophotometer, respectively. rRNA removal and RNA sequencing were performed as previously described \[[@pone.0165019.ref021]\] by staff at Zhejiang Tianke (Hangzhou, China). The raw data from the samples were analyzed using Subread \[[@pone.0165019.ref022], [@pone.0165019.ref023]\], and the raw counts of each sample were normalized and processed using the EdgeR Bioconductor package \[[@pone.0165019.ref024]\]. Genes with adjusted p-values (BH method) less than 0.05 and presenting at least two-fold differences in expression were considered to be differentially expressed.

Complementation experiment {#sec009}
--------------------------

Plasmids carrying wild-type *ramR* or *lon* were constructed and then introduced into laboratory-evolved resistant strains of *K*. *pneumoniae* by electroporation. Briefly, a region including the open reading frame of *ramR* or *lon*, derived from the XH209 genome sequence, was cloned into the pCR 2.1 vector (Invitrogen, USA). The plasmid containing the *ramR* gene and/or *lon* gene was then transferred into the resistant strains. The empty vector (pCR 2.1 vector) was also introduced into the resistant strains as a control. The MIC for tigecycline of the transformants were determined by broth microdilution with MH broth.

Gene knockout {#sec010}
-------------

Mutant *ramR* and *lon* genes were constructed as previously described \[[@pone.0165019.ref025]\]. In brief, the pIJ773 plasmid was used as the template for amplification of an apramycin resistance cassette, and the pACBSR-Hyg plasmid was used for arabinose-inducible λ--Red recombination. The knockout cassette was amplified from the FRT-flanked Apra^R^ cassette of pIJ773 using response primers ([Table 1](#pone.0165019.t001){ref-type="table"}). The PCR-amplified knockout cassette was then transformed into *K*. *pneumoniae* XH209+PACBSR-Hyg, and the transformants were screened overnight in LBApra at 37°C. The loss of pACBSR-Hyg was screened by streaking onto LBApra and low-salt LB + hygromycin plates overnight at 37°C. PCR and Sanger sequencing were performed to confirm the correct insertion of the knockout cassette.

Results {#sec011}
=======

Clinical strains and *in vitro* selection of mutants with tigecycline resistance {#sec012}
--------------------------------------------------------------------------------

We obtained two *K*. *pneumoniae* strains that were isolated from the blood of a patient during tigecycline treatment. The *K*. *pneumoniae* tigecycline MICs increased from 2 mg/L (XH209) to 8 mg/L (XH210). Six independent colonies of XH209 were also selected at increased concentrations of tigecycline. After 13 days of serial passage (every 24 h), we obtained six tigecycline-resistant mutants, and the observed resistance to tigecycline increased in a step-wise manner (fold-increases compared with the MIC of *K*. *pneumoniae* XH209) following tigecycline passaging ([Fig 1](#pone.0165019.g001){ref-type="fig"}). The MICs of the six selected mutants ranged from 64 to 256 mg/L.

![Resistance to tigecycline increased in a stepwise manner (as a fold increase over the MIC of *K*. *pneumoniae* XH209) following serial passage in tigecycline.](pone.0165019.g001){#pone.0165019.g001}

Putative resistance mutations and their fitness costs {#sec013}
-----------------------------------------------------

The whole genomes of the clinical isolates and *in vitro* selection mutants were sequenced to identify mutations that are potentially responsible for resistance to tigecycline. The most commonly observed SNPs were nucleotide substitutions resulting in amino acid changes or stop codons ([Table 2](#pone.0165019.t002){ref-type="table"}). A mutation in *ramR* was found in seven strains. In *K*. *pneumoniae*, the *ramR* gene encodes a repressor of *ramA*, which is known to be associated with resistance to tigecycline and ciprofloxacin \[[@pone.0165019.ref005]\]. RamA is a positive global regulator of the AcrAB efflux system \[[@pone.0165019.ref014]\]. Five strains harbored a *lon* mutation, and a mutation in *rpoC* was detected in three strains. In addition, a 287-kb duplication was observed in the genome of *K*. *pneumoniae* XH212. The biological fitness costs of the clinical isolates and *in vitro* selection mutants were also measured based on their relative growth rates compared with that of XH209. Fitness costs ranging from 2% to 58% were observed in most of the strains, and the costs showed a good correlation with the lag time. Notably, the clinical isolates showed the lowest fitness costs.

10.1371/journal.pone.0165019.t002

###### Characterization of laboratory-evolved tigecycline-resistant *K*. *pneumoniae* and single-step selection of *K*. *pneumoniae* mutants.

![](pone.0165019.t002){#pone.0165019.t002g}

  Strain   Parental strain   Putative mutation(s) causing reduced susceptibility to TGC                               Other genetic changes         TGC MIC (mg/L)   TGC MIC (mg/L) +PaβN (50 mg/L)   Relative growth rate   Lag time (min)   TET     CHL     AK     CTX     CIP    IPM     NI
  -------- ----------------- ---------------------------------------------------------------------------------------- ----------------------------- ---------------- -------------------------------- ---------------------- ---------------- ------- ------- ------ ------- ------ ------- -------
  XH209    NA                NA                                                                                       NA                            2                2                                1                      120              \>256   \>256   2      \>256   0.75   4       64
  XH210    XH209             *ramR* Q122[\*](#t002fn002){ref-type="table-fn"}                                         NA                            16               8                                0.98                   113.44           \>256   \>256   2      \>256   4      4       192
  XH211    XH209             *ramA* Q72L, *lon* Q317[\*](#t002fn002){ref-type="table-fn"} *ramR* Δ190 bp (322--511)   *cspE* N57K                   128              8                                0.42                   232              \>256   \>256   1      1.5     3      0.125   3
  XH212    XH209             P*ramR* +G, *lon* D445V, *rpsJ* V57L                                                     *tetA* I235F, 300 kb dup      \>256            256                              0.59                   183.75           \>256   \>256   1.5    \>256   6      4       16
  XH213    XH209             *ramR* A40T, *lon* R33W, *rpoC* Δ18 bp (634--651)                                        *eutL* E95Q                   \>256            64                               0.46                   223.44           \>256   \>256   0.5    128     3      4       8
  XH214    XH209             *ramR* L58P, *rpoC* G336A                                                                                              64               32                               0.74                   189.06           \>256   \>256   0.75   \>256   2      1       128
  XH215    XH209             *ramR* Q135[\*](#t002fn002){ref-type="table-fn"}, *lon* Δ9 bp (791--799), *rpoC* S263Y   *yfiR* C89Y *hypo* K302T      256              64                               0.56                   187.19           \>256   \>256   0.75   64      3      2       4
  XH216    XH209             *ramR* S29[\*](#t002fn002){ref-type="table-fn"}, *lon* N417K                             Mobile element protein G12E   64               16                               0.55                   241.25           \>256   \>256   0.75   128     2      6       4
  XH490    XH209             *ramR* Q122[\*](#t002fn002){ref-type="table-fn"}                                         ND                            16               ND                               0.98                   123.75           \>256   \>256   1.5    \>256   3      8       128
  XH491    XH209             *ramR* T42Ins (8 bp)                                                                     ND                            8                ND                               0.98                   120              \>256   \>256   1      \>256   3      6       128
  XH492    XH209             *ramR* S137[\*](#t002fn002){ref-type="table-fn"}                                         ND                            16               ND                               0.98                   113.44           \>256   \>256   1      \>256   3      3       192
  XH493    XH209             *ramR* A49Ins (8 bp)                                                                     ND                            16               ND                               0.97                   232              \>256   64      1      \>256   3      3       \>512
  XH494    XH209             *ramR* M1V                                                                               ND                            16               ND                               0.99                   183.75           \>256   \>256   1      \>256   2      4       96
  XH495    XH209             *ramR* W185[\*](#t002fn002){ref-type="table-fn"}                                         ND                            16               ND                               0.97                   223.44           \>256   32      1.5    \>256   4      6       128
  XH496    XH209             *ramR* F45Del (8 bp)                                                                     ND                            16               ND                               0.88                   189.06           \>256   \>256   1.5    \>256   2      1       32
  XH497    XH209             *ramR* A2FS                                                                              ND                            8                ND                               0.98                   187.19           \>256   \>256   1.5    \>256   2      6       64
  XH498    XH209             *ramR* F45Ins (8 bp)                                                                     ND                            16               ND                               0.99                   241.25           \>256   \>256   1.5    \>256   2      3       128
  XH499    XH209             *ramR* R107H                                                                             ND                            16               ND                               0.99                   123.75           \>256   \>256   1.5    \>256   2      3       64
  XH500    XH209             *ramR* W89L                                                                              ND                            16               ND                               0.98                   123.75           \>256   \>256   2      \>256   3      2       96
  XH501    XH209             *ramR* A37V                                                                              ND                            8                ND                               0.99                   122.5            \>256   \>256   1.5    \>256   3      4       128
  XH502    XH209             *ramR* W89[\*](#t002fn002){ref-type="table-fn"}                                          ND                            8                ND                               0.97                   115.31           \>256   \>256   1.5    \>256   3      6       128
  XH503    XH209             *ramR* T119P                                                                             ND                            8                ND                               0.97                   114.38           \>256   \>256   1.5    \>256   3      4       192
  XH504    XH209             *ramR* K5FS                                                                              ND                            8                ND                               0.98                   123.44           \>256   \>256   1.5    \>256   3      4       128
  XH505    XH209             *ramR* A105G                                                                             ND                            8                ND                               0.97                   124.06           \>256   \>256   1.5    \>256   3      4       128

TGC: tigecycline; TET: tetracycline; CHL: chloramphenicol; AK: amikacin; CTX: cefotaxime; CIP: ciprofloxacin; IPM: imipenem;NI: nitrofurantoin. Note: NA: not found;ND: not detect;

\*: Stop codon;

Δ: Deletion; Ins: Insertion; Del: Deletion; FS: Frameshift;

Up-regulation of *the* ram locus in tigecycline-resistant mutants {#sec014}
-----------------------------------------------------------------

In this study, we selected the genes exhibiting at least a two-fold change in expression level in the mutants compared with the wild-type XH209 strain. In total, seven (0.14%), 118 (2.42%), 82 (1.68%), 69 (1.41%), 55 (1.13%), 73 (1.50%) and 30 (0.61%) genes had increased expression in XH210, XH211, XH212, XH213, XH214, XH215 and XH216, respectively. Two (0.04%), 44 (0.90%), 152 (3.11%), 47 (0.96%), 87 (1.78%), 41 (0.84%) and 78 (1.60%) genes showed reduced expression in these strains, respectively. The up-regulation of seven genes was observed in all seven strains. The annotations and reads per kilobase per million mapped reads (RPKM) values are listed in [Table 3](#pone.0165019.t003){ref-type="table"}. These genes can be divided into two groups: one group includes the *ram* locus (the *ramR-romA-ramA* genes) and the efflux pump *acrA*, and the other group includes *gsiA* and *entE*. The *gsiA* gene encodes an ATP-binding protein of a glutathione importer \[[@pone.0165019.ref026]\], and EntE is an enzyme involved in the enterobactin biosynthesis pathway \[[@pone.0165019.ref027]\].

10.1371/journal.pone.0165019.t003

###### Differentially expressed genes in laboratory-evolved strains compared with wild-type and clinical strains.

![](pone.0165019.t003){#pone.0165019.t003g}

  Gene             Gene     Product                                                  XH210                                       XH211   XH212   XH213   XH214   XH215   XH216
  ---------------- -------- -------------------------------------------------------- ------------------------------------------- ------- ------- ------- ------- ------- -------
  up-regulated                                                                                                                                                           
  LQ47_01505                phospholipid ABC transporter substrate-binding protein   2.2[\*](#t003fn001){ref-type="table-fn"}    4.0     4.3     3.5     3.4     3.5     3.8
  LQ47_01510                ABC transporter substrate-binding protein                2.1[\*](#t003fn001){ref-type="table-fn"}    4.0     4.2     3.9     3.1     3.6     4.1
  LQ47_01515                phospholipid ABC transporter substrate-binding protein   2.8[\*](#t003fn001){ref-type="table-fn"}    4.5     4.7     4.5     4.1     4.5     4.9
  LQ47_08715                nitrate/nitrite sensor protein NarX                      -0.5                                        3.0     2.9     3.5     3.0     2.7     2.9
  LQ47_08720                nitrate/nitrite transporter NarK                         -1.1                                        6.2     4.9     5.5     4.9     5.2     5.9
  LQ47_08730                nitrate reductase                                        -0.7                                        5.1     4.5     5.2     4.6     4.3     5.1
  LQ47_08735                nitrate reductase                                        -0.3                                        5.3     4.5     5.5     4.8     4.3     5.3
  LQ47_08740                nitrate reductase                                        -1.0                                        4.4     4.3     4.9     4.9     3.9     4.8
  LQ47_08745                nitrate reductase                                        2.6[\*](#t003fn001){ref-type="table-fn"}    7.1     6.6     7.1     6.7     6.5     7.3
  LQ47_16215                sensor protein BasS/PmrB                                 1.9[\*](#t003fn001){ref-type="table-fn"}    4.0     3.3     4.2     3.9     3.8     4.0
  LQ47_22580                transcriptional regulator                                3.6[\*](#t003fn001){ref-type="table-fn"}    4.9     6.4     5.0     4.9     5.1     5.6
  down-regulated                                                                                                                                                         
  LQ47_02160                hypothetical protein                                     -1.1[\*](#t003fn001){ref-type="table-fn"}   -10.4   -6.8    -5.9    -6.7    -7.4    -8.9
  LQ47_04290                hydrogenase 3 membrane subunit                           -0.5                                        -4.9    -4.1    -6.3    -6.8    -5.9    -4.7
  LQ47_04295                hydrogenase 3 large subunit                              -0.2                                        -5.2    -4.5    -6.2    -6.7    -5.9    -4.9
  LQ47_04310                formate hydrogenlyase maturation protein HycH            -0.6                                        -5.5    -3.7    -6.2    -5.9    -6.1    -4.6
  LQ47_04315                hydrogenase 3 maturation protease                        -0.2                                        -6.8    -5.5    -5.6    -10.9   -10.4   -5.6
  LQ47_04680                fimbrial protein                                         0.1                                         -5.5    -8.2    -7.1    -5.7    -10.8   -7.1
  LQ47_09405                formate dehydrogenase                                    -0.3                                        -5.8    -4.0    -5.2    -5.4    -4.7    -5.0
  LQ47_09545                acetoin reductase                                        -0.5                                        -7.5    -4.8    -7.5    -6.4    -7.8    -7.1
  LQ47_09550                acetolactate synthase                                    -0.4                                        -6.3    -4.5    -6.3    -7.9    -6.7    -5.3
  LQ47_11630                hypothetical protein                                     -3.9[\*](#t003fn001){ref-type="table-fn"}   -5.1    -10.3   -7.7    -10.3   -6.2    -7.8
  LQ47_12010                methionine synthase                                      -2.4                                        -5.4    -8.5    -5.1    -7.4    -6.3    -6.0
  LQ47_23900                5,10-methylenetetrahydrofolate reductase                 -1.5                                        -4.8    -5.7    -6.0    -4.6    -6.1    -5.2
  Common                                                                                                                                                                 
  LQ47_04775       *acrA*   acriflavin resistance protein AcrA                       14.9                                        19.3    14.3    15.1    17.5    15.3    16.8
  LQ47_10655       *gsiA*   glutathione ABC transporter ATP-binding protein          16.4                                        6.3     6.2     7.0     6.9     13.4    14.6
  LQ47_17285       *entE*   enterobactin synthase subunit E                          10.6                                        16.5    17.2    10.2    10.8    19.9    18.2
  LQ47_17585       *ramA*   transcriptional regulator                                5.2                                         6.3     5.3     7.1     5.7     6.8     8.2
  LQ47_17590       *romA*   beta-lactamase                                           6.4                                         14.3    15.2    13.6    14.1    6.8     8.0
  LQ47_17595       *ramR*   TetR family transcriptional regulator                    4.9                                         3.6     5.1     4.9     6.0     4.3     4.9
  LQ47_22005                membrane protein                                         4.2                                         3.8     5.1     5.3     3.6     5.3     4.9

\*: differentially expressed genes in XH210, clinical isolate.

To investigate differences between the clinical and the laboratory-evolved strains, we selected genes that were differentially expressed in the laboratory-evolved strains but not in the clinical strains ([Fig 2](#pone.0165019.g002){ref-type="fig"}). A total of 23 genes were differentially expressed only in the laboratory strains, and these included 11 up-regulated and 12 down-regulated genes ([Table 3](#pone.0165019.t003){ref-type="table"}). After mapping the genes to pathways, we found that several genes involved in nitrogen metabolism were up-regulated ([Fig 3A](#pone.0165019.g003){ref-type="fig"}). In addition, ABC transporters were also induced ([Fig 3B](#pone.0165019.g003){ref-type="fig"}).

![Heatmap of differentially expressed genes in the laboratory-evolved strains but not in the clinical strains.](pone.0165019.g002){#pone.0165019.g002}

![Comparison of the transcriptional profiles of genes in the laboratory-evolved strains with those of the wild-type and clinical strains.\
A). Changes in the transcription of genes involved in nitrogen metabolism between the laboratory-evolved strains and the wild-type and clinical strains. B). ABC transporters were induced in the laboratory-evolved strains. All values show the fold-change differences. The genes depicted in white were not differentially regulated.](pone.0165019.g003){#pone.0165019.g003}

Mutation in *ramR* was dominant in the single-step tigecycline resistance evolution experiment {#sec015}
----------------------------------------------------------------------------------------------

Twenty mutants were obtained through single-step evolution experiments. The Sanger sequencing results for the *ramR* gene in the mutants obtained from the single-step evolution experiments showed that 80% (16/20) of the strains harbored a mutation in *ramR*, including base substitutions, frameshifts, insertions and deletions ([Table 2](#pone.0165019.t002){ref-type="table"}). The tigecycline MICs of the mutants ranged from 8 to 16 mg/L, and the fitness costs ranged from 1 to 12%. Notably, only one strain showed a fitness cost of 12%, whereas the fitness costs of the other strains were not greater than 3%. The structure of *K*. *pneumoniae* RamR was subjected to homology modeling using the SWISS-MODEL workspace, and the mutation sites in the structure were labeled ([Fig 4](#pone.0165019.g004){ref-type="fig"}): five mutations were found to be located in the dimerization domain, and two mutations were localized in the DNA-binding domain.

![Homology modeling of *K*. *pneumoniae* RamR.\
The mutation sites are mapped onto the structure of RamR, and the amino acids are labeled.](pone.0165019.g004){#pone.0165019.g004}

Tigecycline-resistant mutants showed cross-resistance to other antibiotics {#sec016}
--------------------------------------------------------------------------

To test the influence of the mutations on the response of these bacteria to other antibiotics, six different antibiotics belonging to several major classes (tetracycline, chloramphenicol, amikacin, cefotaxime, ciprofloxacin and imipenem) were tested ([Table 2](#pone.0165019.t002){ref-type="table"}). The MICs of the mutants for ciprofloxacin increased from 0.75 mg/L to 2--6 mg/L, which might be caused by up-regulation of an efflux pump gene, *acrA*. Furthermore, XH211 became sensitive to beta-lactams, including cefotaxime and imipenem.

The role of *ramR* and *lon* in tigecycline resistance was confirmed by complementation and gene knockout {#sec017}
---------------------------------------------------------------------------------------------------------

To confirm the roles of *ramR* and *lon* in tigecycline resistance, we cloned the wild-type *ramR* and *lon* genes into the pCR2.1-T vector and introduced the plasmids into the tigecycline-resistant mutants. Tigecycline sensitivity was restored in the XH210 strain carrying the *ramR* plasmid but not in bacteria carrying the empty vector. Analysis of the *in vitro* selection mutants revealed that the plasmid carrying *ramR* or *lon* only partially restored sensitivity to tigecycline ([Table 4](#pone.0165019.t004){ref-type="table"}). It should be noted that the resistant mutant that presented only a partial restoration of sensitivity after transfection of the plasmid harboring both *ramR* and *lon* showed mutations in other genes, such as *ramA*, *rpsJ* and *rpoC*. This result might indicate the involvement of *ramA*, *rpsJ* and *rpoC* in tigecycline resistance.

10.1371/journal.pone.0165019.t004

###### Complementation experiment.

![](pone.0165019.t004){#pone.0165019.t004g}

  TGC MIC (mg/L)   Wild type                                                                         pCR2.1-T vector   pCR2.1-ramR   pCR2.1-lon   pCR2.1-lon-ramR   
  ---------------- --------------------------------------------------------------------------------- ----------------- ------------- ------------ ----------------- ----
  XH210            ramR Q122[\*](#t004fn002){ref-type="table-fn"}                                    8                 8             4                              
  XH211            ramA Q72L lon Q317[\*](#t004fn002){ref-type="table-fn"} ramR Δ190 bp (322--511)   128               64            16           4                 16
  XH212            rpsJ V57L lon D445V PramR +G                                                      256               256           256          128               64
  XH213            ramR A40T lon R33W rpoC Δ18 bp (634--651)                                         128               128           4            64                32
  XH214            ramR L58P rpoC G336A                                                              64                64            8                              
  XH215            ramR Q135[\*](#t004fn002){ref-type="table-fn"} lon Δ9 bp (791--799) rpoC S263Y    256               128           8            16                32
  XH216            ramR S29[\*](#t004fn002){ref-type="table-fn"} lon N417K                           64                64            32           64                32

Note:

\*: stop codon;

Δ: deletion; bp: base pair; NA: no mutation.

The roles of *ramR* and *lon* in tigecycline resistance in *K*. *pneumoniae* were also verified by gene knockout. The *ramR* and *lon* genes were knocked out in the XH209 strain, and the resulting mutants displayed higher tigecycline resistance than the wild-type strain, although the tigecycline MIC of the *ramR* mutant was higher than that of the *lon* mutant ([Table 5](#pone.0165019.t005){ref-type="table"}). Moreover, the relative growth rate of the *ramR* and *lon* mutants were measured, and both showed slower growth in MH medium compared with the wild-type strain.

10.1371/journal.pone.0165019.t005

###### Tigecycline MICs and relative growth rates of *K*. *pneumoniae* XH209 and its isogenic mutants.

![](pone.0165019.t005){#pone.0165019.t005g}

  Strain   Genotype       TGC MIC (mg/L)   Relative growth rate   
  -------- -------------- ---------------- ---------------------- -------
  XH209    wt             2                1                      100.0
  XH872    Δ*ramR*::apr   16               12                     93.6
  XH889    Δ*lon*::apr    8                3                      96.3

Discussion {#sec018}
==========

In this study, we found that the MICs for tigecycline increased in a step-wise manner with the presence of mutations in the *ramR* operon and the *lon* and *rpsJ* genes. Our transcriptional analysis results showed that the *ramR* operon is highly expressed in all seven tigecycline-resistant *K*. *pneumoniae* strains, indicating that the *ramR* operon plays an important role in tigecycline resistance in *K*. *pneumoniae*. The *ramR* gene, located upstream of *ramA*, encodes a transcriptional repressor belonging to the TetR family, and a mutation in *ramR* leads to the overexpression of *ramA* \[[@pone.0165019.ref028], [@pone.0165019.ref029]\]. This regulation is achieved via the binding of RamR to the promoter of *ramA* \[[@pone.0165019.ref030]\]. Nonsynonymous mutations in *ramR* are reported with high frequency in tigecycline-non-susceptible *K*. *pneumoniae* clinical isolates \[[@pone.0165019.ref007]\]. We also identified base substitutions, insertions and deletions in the *ramR* gene (7/7) in *K*. *pneumoniae*, confirming these previous findings. These results indicate that *ramR* mutation is a common mechanism involved in tigecycline resistance.

The Lon protease is involved in the degradation of MarA in *Escherichia coli* \[[@pone.0165019.ref031]\]. A loss-of-function mutation in *lon* would lead to higher concentrations of MarA, which would increase expression of the AcrAB efflux pump. We detected three different types of point mutations in the *lon* gene, and complementation and gene knockout experiments demonstrated that *lon* mutants exhibited higher resistance to tigecycline than wild-type *K*. *pneumoniae*. Inactivation of *lon* is involved in the mechanism of tigecycline resistance in *E*. *coli* and *S*. *Typhimurium* \[[@pone.0165019.ref032], [@pone.0165019.ref033]\]. To the best of our knowledge, this study includes the first construction of a *lon* mutant in *K*. *pneumoniae*, which allowed confirmation of the association of mutations in this gene with tigecycline resistance. A transcript analysis showed that XH211, XH212, XH215 and XH216 presented higher expression levels of *oqxAB* compared with the wild-type strain. These results suggest that RarA and OqxAB play an important role in laboratory-evolved tigecycline-resistant strains \[[@pone.0165019.ref034]\], whereas the expression of *oqxAB* might be regulated by *lon* in all four strains that harbor *lon* mutations.

RpsJ is thought to act as a general target of tigecycline adaption and a marker for alterations in antibiotic resistance in bacteria \[[@pone.0165019.ref035]\]. The protein encoded by the *rpsJ* gene is a component of the 30S ribosomal subunit and participates in the formation of a BoxA-binding module \[[@pone.0165019.ref036]\]. Villa *et al*. reported an amino acid substitution of V57L in *K*. *pneumoniae rpsJ* \[[@pone.0165019.ref008]\], and our results confirmed the presence of this amino acid substitution in this gene. The V57L mutation might cause weaker binding of tigecycline to 16S rRNA, leading to tigecycline resistance \[[@pone.0165019.ref008]\]. The S10 mutation has also been reported in *Enterococcus faecium*, *E*. *coli*, *Staphylococcus aureus*, *Streptococcus pneumoniae* and *Acinetobacter baumannii* \[[@pone.0165019.ref035], [@pone.0165019.ref037], [@pone.0165019.ref038]\]. However, we did not achieve *rpsJ* knockout in *K*. *pneumoniae*. In addition, all attempts to achieve allelic replacement at this locus in *E*. *coli*, *A*. *baumannii* and *E*. *faecium* have failed \[[@pone.0165019.ref035], [@pone.0165019.ref039]\]. This failure could be due to the essential role of S10 in translation and transcription.

Overall, the dominant genetic mutations associated with tigecycline resistance in *K*. *pneumoniae* were found in the *ramR*, *lon* and *rpsJ* genes. Furthermore, the *ramR* locus was found to be highly expressed in all tigecycline-resistant strains. A higher fitness cost was observed in the laboratory-evolved strains but not in the clinical strains. We found differences in the transcriptional changes between the laboratory-evolved tigecycline-resistant mutants and the clinical tigecycline-resistant isogenic strains. Complementation experiments and knockout construction confirmed the roles of *ramR* and *lon* in tigecycline resistance in *K*. *pneumoniae*. We believe that we are the first to construct a *lon* mutant in *K*. *pneumoniae*, which allowed us to confirm its association with tigecycline resistance. These results suggest that the *ramR* operon and the *lon* and *rpsJ* genes play central roles in tigecycline resistance in *K*. *pneumoniae*.

Nucleotide Sequence Accession Numbers {#sec019}
=====================================

The nucleotide sequences of XH209 have been deposited at DDBJ/EMBL/GenBank under the accession number CP009461. The whole-genome shotgun sequencing results for XH210, XH211, XH212, XH213, XH214, XH215 and XH216 have been deposited at DDBJ/EMBL/GenBank under the accession numbers JUGC00000000, JTEA00000000, JTEB00000000, JTGO00000000, JTJA00000000, JUBD00000000 and JUBE00000000, respectively.
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